These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oral microbiome alterations of healthy volunteers with proton pump inhibitor. Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152 [TBL] [Abstract][Full Text] [Related]
4. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies. Macke L; Schulz C; Koletzko L; Malfertheiner P Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420 [TBL] [Abstract][Full Text] [Related]
5. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease. Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880 [TBL] [Abstract][Full Text] [Related]
6. Influence of proton pump inhibitors on microbiota in chronic liver disease patients. Yamamoto K; Ishigami M; Honda T; Takeyama T; Ito T; Ishizu Y; Kuzuya T; Hayashi K; Goto H; Hirooka Y Hepatol Int; 2019 Mar; 13(2):234-244. PubMed ID: 30737678 [TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study. Xiao X; Zhang X; Wang J; Liu Y; Yan H; Xing X; Yang J Gut; 2024 Jun; 73(7):1098-1109. PubMed ID: 38267200 [TBL] [Abstract][Full Text] [Related]
8. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients. Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Horvath A; Rainer F; Bashir M; Leber B; Schmerboeck B; Klymiuk I; Groselj-Strele A; Durdevic M; Freedberg DE; Abrams JA; Fickert P; Stiegler P; Stadlbauer V Sci Rep; 2019 Aug; 9(1):12000. PubMed ID: 31427714 [TBL] [Abstract][Full Text] [Related]
11. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study. Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620 [TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. Bruno G; Zaccari P; Rocco G; Scalese G; Panetta C; Porowska B; Pontone S; Severi C World J Gastroenterol; 2019 Jun; 25(22):2706-2719. PubMed ID: 31235994 [TBL] [Abstract][Full Text] [Related]
14. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients. Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821 [TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients. Li XB; Chu XJ; Cao NW; Wang H; Fang XY; Fan YG; Li BZ; Ye DQ BMC Microbiol; 2022 Apr; 22(1):117. PubMed ID: 35477382 [TBL] [Abstract][Full Text] [Related]
16. Investigation of Enterogermina's Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME Technology. Duysburgh C; Verstrepen L; Broeck MVD; Righetto Z; Perez M Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771360 [TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors alter the composition of the gut microbiota. Jackson MA; Goodrich JK; Maxan ME; Freedberg DE; Abrams JA; Poole AC; Sutter JL; Welter D; Ley RE; Bell JT; Spector TD; Steves CJ Gut; 2016 May; 65(5):749-56. PubMed ID: 26719299 [TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis. Bajaj JS; Acharya C; Fagan A; White MB; Gavis E; Heuman DM; Hylemon PB; Fuchs M; Puri P; Schubert ML; Sanyal AJ; Sterling RK; Stravitz TR; Siddiqui MS; Luketic V; Lee H; Sikaroodi M; Gillevet PM Am J Gastroenterol; 2018 Aug; 113(8):1177-1186. PubMed ID: 29872220 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors. Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470 [TBL] [Abstract][Full Text] [Related]
20. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial. Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]